Cannabis
Calyx Provides Update on Timing for Filing of Annual Financial Statements and First Quarter Interim Financial Statements
Vancouver, British Columbia–(Newsfile Corp. – May 29, 2020) – Calyx Ventures Inc. (TSXV: CYX) (the “Company“) announces that the Company will continue to rely on the temporary 45-day extension for the filing deadline of its annual financial statements, the accompanying management’s discussion and analysis, and the related officer certifications (collectively, the “Annual Filings“) for the year ended December 31, 2019, and will also rely on the extension in respect of its interim financial statements, the accompanying management’s discussion and analysis and the related officer certificates (collectively, the “Interim Filings“) for the three-month period ended March 31, 2020, as granted by the Canadian Securities Administrators in response to the ongoing COVID-19 pandemic.
Prior to the extension, the Company was required to file the Annual Filings by April 29, 2020 and the Interim Filings by June 1, 2020, respectively. Relying on B.C. Instrument 51-515 (Temporary Exemption from Certain Corporate Finance Requirements), affording the Company an additional 45-days from the deadline to file, the Company expects to file the Annual Filings, and the Interim Filings, on or before June 14, 2020.
There have been no undisclosed material business developments since the filing of the last interim financial report. The Company acknowledges that management and other insiders are subject to a trading black-out policy that reflects the principles in Section 9 of National Policy 11-207 (Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions).
For further information about Calyx, please visit www.calyxbio.com or contact:
Roger Forde
President and Chief Executive Officer
Calyx Ventures Inc.
Tel: 604.880.8822
Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the anticipated timeline for filing of the Annual Filings and the Interim Filings. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56908
Cannabis
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis1 week ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis6 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan6 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis2 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis1 day ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis6 hours ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032